Overview

Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery

Status:
Recruiting

Trial end date:
2024-01-01

Target enrollment:

Participant gender:

Summary

This study will test the benefits and risks of using pregabalin perioperatively to prevent persistent postoperative pain in patients at high risk (>30%) of developing such pain after breast cancer surgery.

Phase:

Phase 3

Details

Lead Sponsor:

Benno Rehberg-Klug

Collaborators:

Centre Hospitalier Universitaire Vaudois
University Hospital Inselspital, Berne
University Hospital, Geneva

Treatments:

Pregabalin